Experian : Notice of AGM

Annual

General Meeting

2023

This document is important and requires your immediate attention.

If you are in any doubt about what you should do, we recommend that you immediately obtain financial advice from your stockbroker, bank manager, solicitor, accountant or other independent professional adviser authorised under Part VI of the UK Financial Services and Markets Act 2000, or, if you are in a territory outside the UK, from another appropriately authorised independent financial adviser.

If you have sold or otherwise transferred all your Experian plc ordinary shares, please send this document, together with the accompanying documents, as soon as possible to the purchaser or transferee or to the stockbroker, bank or other person through whom you sold or transferred the shares, so they can be passed on to the purchaser or transferee.

Highlights

"We delivered very strong results in FY23, reflecting a combination of new business wins, new products and expansion into higher growth markets. We saw growth in every region, in many cases outperforming our underlying markets substantially. Total revenue growth from ongoing activities was 6% at actual exchange rates and 8% at constant exchange rates, and organic revenue growth was 7%. Benchmark EBIT margin expansion was at the top end of our expectations, helping us to deliver Benchmark earnings per share up 9%.

"For the year ahead, we anticipate another year of growth due to the breadth and the resilience of our portfolio, and significant structural growth opportunities. Despite the uncertain economic climate, we expect to deliver organic revenue growth in the range of 4% to 6% and modest margin accretion, all at constant exchange rates and on an ongoing basis."

Brian Cassin

Chief Executive Officer

Financial highlights

Growth % at

Statutoryactual FX rates Revenue

US$6,619m+5%

(2022: US$6,288m)

Operating profit

US$1,265m-11%

(2022: US$1,416m)

Profit before tax

US$1,174m-19%

(2022: US$1,447m)

Basic EPS

USc84.2 -34%

(2022: USc127.5)

1 From ongoing activities.

	Growth % at Growth % at
Benchmark	actual FX	constant FX
rates	rates
Revenue - ongoing
activities	+6%	+8%
US$6,587m
(2022: US$6,216m)
Benchmark EBIT¹
US$1,802m	+9%	+9%
(2022: US$1,653m)
Benchmark profit before
tax	+9%	+9%
US$1,670m
(2022: US$1,535m)
Benchmark EPS
USc135.1	+9%	+9%

(2022: USc124.5)

The results for the year ended 31 March 2022 have been re-presented for the reclassification to exited business activities of certain Business-to-Business (B2B) businesses. See Note 10a(i) to the Group financial statements for Revenue - ongoing activities and Benchmark EBIT re-presentation.

Experian plc	3
Letter from the Chair

Letter from the Chair

9 June 2023

To holders of ordinary shares

Dear Shareholder

Annual General Meeting: 19 July 2023

I am writing with details of our Annual General Meeting (AGM), which will be held on Wednesday 19 July 2023 at 9.30am at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland.

We regard the AGM as an important forum for engaging with shareholders, particularly private shareholders, and we welcome your questions. If you cannot attend in person, you may submit questions about the AGM's business in advance, by email to [e-mail] or on the reply paid question card attached to the proxy form. We will consider all questions and, if appropriate, address them at the AGM, via Experian's website (www.experianplc.com) or individually.

The notice of meeting and notes are set out on pages 4 to 7 of this document. An explanation of the resolutions being proposed at the meeting is set out in Appendix 1. Voting will be taken on a poll, except for any procedural resolution which may be taken on a show of hands. I encourage you to use your vote by attending in person, voting electronically online or completing and returning a proxy form by post. You may place your proxy form in an envelope addressed to the Company's share registrars. A postage stamp is not needed if you post the form in the UK and, should shareholders wish, proxy forms may be placed in an envelope and addressed to the Company's registrars. You should return your completed form as soon as possible but it must arrive no later than 9.30am on Monday 17 July 2023. Returning a proxy form or voting electronically will not prevent you from attending the meeting in person. If you wish to vote electronically, you can do so by registering for the Link Share Portal service, at www.experianplc.com/ shares, or as otherwise outlined in this notice of meeting.

Further details of how to vote are included in the 'Information for shareholders' section at the end of this document. Shareholders entitled to attend, speak and vote at the AGM may appoint a proxy to exercise their rights in their place. You may appoint more than one proxy, provided that you appoint each proxy to exercise the rights attached

to different shares.

Experian plc (incorporated and registered in Jersey. No. 93905)

Corporate headquarters: 2 Cumberland Place, Fenian Street, Dublin 2, D01 HY05, Ireland

Registered office: 22 Grenville Street, St. Helier, Jersey, JE4 8PX, Channel Islands

The directors have announced a second interim dividend of 37.75 US cents per ordinary share, to be paid on 21 July 2023 to holders of the Company's ordinary shares on 23 June 2023. To ensure that certain UK shareholders have the same tax treatment on their dividend as if the Company was based in the UK, we have Income Access Share arrangements in place. The mechanics of these arrangements make it impractical to submit a proposed dividend for approval at the AGM, but the Board has no plans to announce any additional dividend in respect of the year ended 31 March 2023.

The directors consider that all the resolutions to be put to the AGM are in the best interests of the Company and its shareholders as a whole. Accordingly, the directors unanimously recommend that you vote in favour of all resolutions, as they intend to do in respect of their own beneficial shareholdings.

Yours faithfully

Mike Rogers

Chair

4	Experian plc
Notice of the Annual General Meeting

Notice of Meeting

Notice is hereby given that the 2023 Annual General Meeting of Experian plc (the Company) will be held at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland on Wednesday 19 July 2023 at 9.30am.

Explanatory notes regarding the resolutions set out below are contained in Appendix 1.

You will be asked to consider and, if thought fit, pass the following resolutions.

Ordinary resolutions

1. To receive the Annual Report and financial statements of the Company for the year ended 31 March 2023, together with the report of the auditor.
2. To approve the Report on directors' remuneration (excluding the Directors' remuneration policy set out on pages 140 to 145 of the report) contained in the Annual Report and financial statements of the Company for the year ended 31 March 2023.
3. To approve the Directors' remuneration policy set out on pages 140 to 145 of the Report on director's remuneration contained in the Annual Report and financial statements of the Company for the year ended 31 March 2023.
4. To elect Craig Boundy as a director of the Company.
5. To elect Kathleen DeRose as a director of the Company.
6. To elect Esther Lee as a director of the Company.
7. To elect Louise Pentland as a director of the Company.
8. To re-elect Alison Brittain as a director of the Company.
9. To re-elect Brian Cassin as a director of the Company.
10. To re-elect Caroline Donahue as a director of the Company.
11. To re-elect Luiz Fleury as a director of the Company.
12. To re-elect Jonathan Howell as a director of the Company.
13. To re-elect Lloyd Pitchford as a director of the Company.
14. To re-elect Mike Rogers as a director of the Company.
15. To re-appoint KPMG LLP as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company.
16. To authorise the directors to determine the remuneration of the auditor.
17. That the authority conferred on the directors by article 10.2 of the Company's articles of association be renewed and for this purpose the directors be generally and unconditionally authorised to exercise all the powers of the Company to allot shares or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of US$30,638,482 (being the Authorised Allotment Amount for the purposes of the articles of association of the Company), and the Allotment Period (as defined in the articles of association of the Company) shall be the period commencing on 19 July 2023 and ending on the conclusion of the Annual General Meeting to be held in 2024 or, if earlier, 18 October 2024, unless previously renewed, varied or revoked by the Company

in general meeting except that the Company may before such expiry make an offer or agreement which would or might require shares to be allotted or rights to subscribe for or to convert any security into shares to be granted after such expiry and the directors may allot shares or grant rights to subscribe for or convert any security into shares in pursuance of such an offer or agreement as if the authority conferred hereby had not expired.

Special resolutions

18. Subject to the passing of resolution 17, and for the period referred to in resolution 17, that:

1. the authority conferred on the directors by article 10.3 of the Company's articles of association shall be renewed and for this purpose the Non-pre-emptive Amount (as defined in the articles of association of the Company) shall be US$9,191,544; and
2. in addition to the authority conferred on the directors by article 10.3 of the Company's articles of association, the directors be authorised to allot equity securities (as defined in the articles of association of the Company) and/or to sell ordinary shares held by the Company as treasury shares wholly for cash pursuant to the authority conferred by resolution 17 as if article 11 of the articles of association of the Company did not apply to any such allotment or sale, provided that such allotments or sales are: (i) made otherwise than pursuant to article 10.3 of the Company's articles of association; and (ii) limited to an aggregate nominal amount equal to 20% of any allotment of equity securities (or sale of treasury shares) made from time to time under article 10.3(b) of the Company's articles of association, such authority to be used only for the purposes of making a follow-on offer which the directors determine to be of a kind contemplated by paragraph 3 of section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the UK Pre-Emption Group prior to the date of this notice,

such authority to expire at the end of the Allotment Period specified in resolution 17 except that the Company may, in each case, before such expiry, make offers and enter into agreements which would or might require equity securities to be allotted (and treasury shares to be sold) after such expiry and the directors may allot equity securities (and sell treasury shares) in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.

19. Subject to the passing of resolution 17, that the directors be authorised, in addition to any authority granted under resolution 18, to allot equity securities (as defined in the articles of association of the Company) wholly for cash pursuant to the authority conferred by resolution 17 and/or to sell ordinary shares held by the Company as treasury shares for cash as if article 11 of the articles of association of the Company did not apply to any such allotment or sale, such authority to be limited to allotment of equity securities or sale of treasury shares up to an aggregate nominal amount of US$9,191,544 such authority to be:

5

1. used only for the purposes of financing (or refinancing, if the authority is to be used within twelve months after the original transaction) a transaction which the directors determine to be either an acquisition or a specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the UK Pre-Emption Group prior to the date of this notice; and
2. otherwise than under paragraph (a) of this resolution 19, allotments of up to an aggregate nominal amount equal to 20% of any allotment (or sale of treasury shares) made from time to time under paragraph (a) of this resolution 19, such authority to be used only for the purposes of making a follow-on offer which the directors determine to be of a kind contemplated by paragraph 3 of section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the UK Pre-Emption Group prior to the date of this notice,

such authority to expire at the end of the Allotment Period specified in resolution 17 except that the Company may, in each case, before such expiry, make offers and enter into agreements which would or might require equity securities to be allotted (and treasury shares to be sold) after such expiry and the directors may allot equity securities (and sell treasury shares) in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.

20. To authorise the Company, generally and unconditionally:

1. pursuant to Article 57 of the Companies (Jersey) Law 1991, to make market purchases of ordinary shares in the capital of the Company on the London Stock Exchange on behalf of the Company on such terms and in such manner as the directors may from time to time determine, provided that:
2. 1. the maximum number of ordinary shares which may be purchased under this authority is 91,915,447 ordinary shares of 10 US cents each;
   2. the minimum price (not including expenses) which may be paid for each ordinary share is 10 US cents;
   3. the maximum price (not including expenses) which may be paid for each ordinary share is an amount equal to the higher of: (a) 105% of the average market value of the Company's ordinary shares as derived from The London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the relevant share is purchased; and (b) the higher of the price of the last independent trade and the highest current independent bid for an ordinary share on the exchange on which the purchase is to be carried out; and
   4. the authority hereby conferred shall expire on the earlier of 18 October 2024 and the conclusion of the Annual General Meeting of the Company to be held in 2024 (except that the Company shall be entitled, at any time prior to the expiry of this authority, to make a contract to purchase which would or might be executed wholly or partly after such expiry and to purchase shares in accordance with such contract as
      if the authority conferred had not expired) unless such authority is renewed prior to such time; and

1. pursuant to Article 58A of the Companies (Jersey) Law 1991, and if approved by the directors, to hold as treasury shares any ordinary shares purchased pursuant to the authority conferred by paragraph (a) of this resolution.

By order of the Board

Charles Brown

Company Secretary

9 June 2023

Corporate headquarters:	Registered office:
2 Cumberland Place	22 Grenville Street
Fenian Street	St Helier
Dublin 2	Jersey
D02 HY05	JE4 8PX
Ireland	Channel Islands